Biomonitoring as a tool in the human health risk characterization of dermal exposure

Human and Experimental Toxicology

Volumn 27, Issue 4, 2008, Pages 297-305

  Boogaard, P J ^a  

^a SHELL GLOBAL SOLUTIONS INTERNATIONAL B V   (United States)

Author keywords

Biomonitoring; Dermal exposure; EASE; Risk assessment; RISKOFDERM

Indexed keywords

1 METHOXY 2 PROPANOL; 2 BUTOXYETHANOL; CHEMICAL AGENT; PROPANOL; STYRENE; UNCLASSIFIED DRUG; ETHYLENE GLYCOL DERIVATIVE; N BUTOXYETHANOL; N-BUTOXYETHANOL; PROPANEDIOL DERIVATIVE; PROPYLENE GLYCOL METHYL ETHER; XENOBIOTIC AGENT;

BIOLOGICAL MONITORING; HEALTH HAZARD; HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN ABSORPTION; SKIN PENETRATION; ARTICLE; BIOLOGICAL MODEL; COMPARATIVE STUDY; DRUG EFFECT; ENVIRONMENTAL MONITORING; METABOLISM; METHODOLOGY; SKIN;

ENVIRONMENTAL MONITORING; ETHYLENE GLYCOLS; HUMANS; MODELS, BIOLOGICAL; OCCUPATIONAL EXPOSURE; PROPYLENE GLYCOLS; RISK ASSESSMENT; SKIN; SKIN ABSORPTION; STYRENE; XENOBIOTICS;

EID: 52649161796     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327107085830     Document Type: Review

References (75)

1. EC. Technical Guidance Document on Risk Assessment in support of Commission Directive 93/67/EEC on risk assessment for new notified substances, Commission regulation (EC) No 1488/94 on risk assessment for existing substances, Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, Part 1. Ispra: EU Joint Research Centre; 2003.
2. ECETOC. Strategy for assigning a "skin notation. Document No. 31. Brussels: ECETOC ; 1993.
3. ECETOC. Examination of a proposed skin notation strategy. Special report No. 15. Brussels: ECETOC ; 1998.
4. Bos PM Brouwer DH Stevenson H Boogaard PJ de Kort WL van Hemmen JJ. Proposal for the assessment of quantitative dermal exposure limits in occupational environments: Part 1. Development of a concept to derive a quantitative dermal occupational exposure limit. Occup Environ Med 1998 ; 55: 795-804.
5. Brouwer EJ Verplanke AJ Boogaard PJ Bloemen LJ Van Sittert NJ Christian FE. Personal air sampling and biological monitoring of occupational exposure to the soil fumigant cis-1,3-dichloropropene. Occup Environ Med 2000 ; 57: 738-744.
6. Williams F. Hum Exp Toxicol 2007 ; this volume [submitted].
7. Boogaard PJ Denneman MA Van Sittert NJ. Dermal penetration and metabolism of five glycidyl ethers in human, rat and mouse skin. Xenobiotica 2000 ; 30: 469-483.
8. Van Hemmen JJ Brouwer DH. Assessment of dermal exposure to chemicals. Sci Total Environ 1995 ; 168: 131-141.
9. Kezic S. Methods for measuring in vivo percutaneous absorption in humans. Hum Exp Toxicol 2007 ; this volume (submitted).
10. Van Hemmen JJ. EUROPOEM, a predictive occupational exposure database for registration purposes of pesticides. Appl Occup Environ Hyg 2001 ; 16: 246-250.
11. Koontz M Price P Hamilton J Daggett D Sielken R Bretzlaff R. Modeling aggregate exposures to glycol ethers from use of commercial floor products. Int J Toxicol 2006 ; 25: 95-107.
12. Cherrie JW Hughson GW. The validity of the EASE expert system for inhalation exposures. Ann Occup Hyg 2005 ; 49: 125-134.
13. Creely KS Tickner J Soutar AJ Hughson GW Pryde DE Warren ND. Evaluation and further development of EASE model 2.0. Ann Occup Hyg 2005 ; 49: 135-145.
14. Tickner J Friar J Creely KS Cherrie JW Pryde DE Kingston J. The development of the EASE model. Ann Occup Hyg 2005 ; 49: 103-110.
15. Schneider T Vermeulen R Brouwer DH Cherrie JW Kromhout H Fogh CL. Conceptual model for assessment of dermal exposure. Occup Environ Med 1999 ; 56: 765-773.
16. Van Wendel de Joode B van Hemmen JJ Meijster T Major V London L Kromhout H. Reliability of a semi-quantitative method for dermal exposure assessment (DREAM). J Expo Anal Environ Epidemiol 2005 ; 15: 111-120. (Pubitemid 40170990)
17. Van Wendel de Joode B Vermeulen R van Hemmen JJ Fransman W Kromhout H. Accuracy of a semiquantitative method for Dermal Exposure Assessment (DREAM). Occup Environ Med 2005 ; 62: 623-632.
18. Van-Wendel-de-Joode B Brouwer DH Vermeulen R Van Hemmen JJ Heederik D Kromhout H. DREAM: a method for semi-quantitative dermal exposure assessment. Ann Occup Hyg 2003 ; 47: 71-87.
19. Van Hemmen JJ Auffarth J Evans PG Rajan-Sithamparanadarajah B Marquart H Oppl R. RISKOFDERM: risk assessment of occupational dermal exposure to chemicals. An introduction to a series of papers on the development of a toolkit. Ann Occup Hyg 2003 ; 47: 595-598.
20. Northage C. EASEing into the future. Ann Occup Hyg 2005 ; 49: 99-101.
21. Oppl R Kalberlah F Evans PG van Hemmen JJ. A toolkit for dermal risk assessment and management: an overview. Ann Occup Hyg 2003 ; 47: 629-640.
22. Marquart H Warren ND Laitinen J van Hemmen JJ. Default values for assessment of potential dermal exposure of the hands to industrial chemicals in the scope of regulatory risk assessments. Ann Occup Hyg 2006 ; 50: 469-489.
23. Goede HA Tijssen SC Schipper HJ Warren N Oppl R Kalberlah F. Classification of dermal exposure modifiers and assignment of values for a risk assessment toolkit. Ann Occup Hyg 2003 ; 47: 609-618. (Pubitemid 37432607)
24. Hebisch R Auffarth J. Dermal exposure: how to get information. Appl Occup Environ Hyg 2001 ; 16: 169-173.
25. Hughson GW Aitken RJ. Determination of dermal exposures during mixing, spraying and wiping activities. Ann Occup Hyg 2004 ; 48: 245-255.
26. Kromhout H Fransman W Vermeulen R Roff M van Hemmen JJ. Variability of task-based dermal exposure measurements from a variety of workplaces. Ann Occup Hyg 2004 ; 48: 187-196.
27. Gijsbers JH Tielemans E Brouwer DH van Hemmen JJ. Dermal exposure during filling, loading and brushing with products containing 2-(2-butoxyethoxy) ethanol. Ann Occup Hyg 2004 ; 48: 219-227.
28. Rajan-Sithamparanadarajah R Roff M Delgado P Eriksson K Fransman W Gijsbers JH. Patterns of dermal exposure to hazardous substances in European union workplaces. Ann Occup Hyg 2004 ; 48: 285-297.
29. Roff M Bagon DA Chambers H Dilworth EM Warren N. Dermal exposure to dry powder spray paints using PXRF and the method of Dirichlet tesselations. Ann Occup Hyg 2004 ; 48: 257-265.
30. Warren ND Marquart H Christopher Y Laitinen J. VANH, JJ. Task-based dermal exposure models for regulatory risk assessment. Ann Occup Hyg 2006 ; 50: 491-503.
31. Ponec M Boelsma E Gibbs S Mommaas M. Characterization of reconstructed skin models. Skin Pharmacol Appl Skin Physiol 2002 ; 15 (Suppl. 1): 4-17.
32. Monteiro-Riviere NA Inman AO Snider TH Blank JA Hobson DW. Comparison of an in vitro skin model to normal human skin for dermatological research. Microsc Res Tech 1997 ; 37: 172-179.
33. Boogaard PJ van Elburg PA de Kloe KP Watson WP van Sittert NJ. Metabolic inactivation of 2-oxiranylmethyl 2-ethyl-2,5-dimethylhexanoate (C10GE) in skin, lung and liver of human, rat and mouse. Xenobiotica 1999 ; 29: 987-1006.
34. Nasseri-Sina P Hotchkiss SA Caldwell J. Cutaneous xenobiotic metabolism: glycine conjugation in human and rat keratinocytes. Food Chem Toxicol 1997 ; 35: 409-416.
35. Smith CK Moore CA Elahi EN Smart AT Hotchkiss SA. Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde, and cinnamic alcohol. Toxicol Appl Pharmacol 2000 ; 168: 189-199.
36. Carver MP Williams PL Riviere JE. The isolated perfused porcine skin flap. III. Percutaneous absorption pharmacokinetics of organophosphates, steroids, benzoic acid, and caffeine. Toxicol Appl Pharmacol 1989 ; 97: 324-337.
37. Riviere JE Bowman KF Monteiro-Riviere NA Dix LP Carver MP. The isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies. Fundam Appl Toxicol 1986 ; 7: 444-453.
38. Riviere JE Monteiro-Riviere NA. The isolated perfused porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology. Crit Rev Toxicol 1991 ; 21: 329-344.
39. Frasch HF. A random walk model of skin permeation. Risk Anal 2002 ; 22: 265-276.
40. Guy RH Potts RO. Penetration of industrial chemicals across the skin: a predictive model. Am J Ind Med 1993 ; 23: 711-719.
41. McKone TE Howd RA. Estimating dermal uptake of nonionic organic chemicals from water and soil: I. Unified fugacity-based models for risk assessments. Risk Anal 1992 ; 12: 543-557.
42. Patel H ten Berge W Cronin MT. Quantitative structure-activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals. Chemosphere 2002 ; 48: 603-613.
43. Wilschut A ten Berge WF Robinson PJ McKone TE. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 1995 ; 30: 1275-1296.
44. Hakkert BC. Refinement of risk assessment of dermally and intermittently exposed pesticide workers: a critique. Ann Occup Hyg 2001 ; 45 (Suppl. 1): S23-S28.
45. Jakasa I de Jongh CM Verberk MM Bos JD Kezic S. Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol 2006 ; 155: 104-109.
46. Jakasa I Verberk MM Bunge AL Kruse J Kezic S. Increased permeability for polyethylene glycols through skin compromised by sodium lauryl sulphate. Exp Dermatol 2006 ; 15: 801-807.
47. Jakasa I Verberk MM Esposito M Bos JD Kezic S. Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol 2007 ; 127: 129-134.
48. Maibach HI Feldman RJ Milby TH Serat WF. Regional variation in percutaneous penetration in man. Pesticides. Arch Environ Health 1971 ; 23: 208-211.
49. Scheuplein RJ Blank IH. Permeability of the skin. Physiol Rev 1971 ; 51: 702-747.
50. Benford DJ Cocker J Sartorelli P Schneider T van Hemmen J Firth JG. Dermal route in systemic exposure. Scand J Work Environ Health 1999 ; 25: 511-520.
51. ECETOC. Guidance for the interpretation of biomonitoring data. Document 44. Brussels: ECETOC ; 2005.
52. Boogaard PJ. MCD. A proposed framework for the interpretation of biomonitoring data. Int J Hyg Environ Health 2007 (in press).
53. Eriksson K Wiklund L. Dermal exposure to styrene in the fibreglass reinforced plastics industry. Ann Occup Hyg 2004 ; 48: 203-208.
54. Guillemin MP Berode M. Biological monitoring of styrene: a review. Am Ind Hyg Assoc J 1988 ; 49: 497-505.
55. INSERM. Ethers de glycol-Quels risques pour la santé? Chpt. 10 Surveillance biologique de lexposition. Paris: INSERM; 1999. p. 263-270.
56. Jones K Cocker J. A human exposure study to investigate biological monitoring methods for 2-butoxyethanol. Biomarkers 2003 ; 8: 360-370.
57. Söhnlein B Letzel S Weltle D Rudiger HW Angerer J. Occupational chronic exposure to organic solvents. XIV. Examinations concerning the evaluation of a limit value for 2-ethoxyethanol and 2-ethoxyethyl acetate and the genotoxic effects of these glycol ethers. Int Arch Occup Environ Health 1993 ; 64: 479-484.
58. Vincent R Rieger B Subra I Poirot P. Exposure assessment to glycol ethers by atmosphere and biological monitoring. Occup Hyg 1996 ; 2: 79-99.
59. Haufroid V Thirion F Mertens P Buchet JP Lison D. Biological monitoring of workers exposed to low levels of 2-butoxyethanol. Int Arch Occup Environ Health 1997 ; 70: 232-236.
60. Angerer J Lichterbeck E Begerow J Jekel S Lehnert G. Occupational chronic exposure to organic solvents. XIII. Glycolether exposure during the production of varnishes. Int Arch Occup Environ Health 1990 ; 62: 123-126.
61. Laitinen J. Correspondence between occupational exposure limit and biological action level values for alkoxyethanols and their acetates. Int Arch Occup Environ Health 1998 ; 71: 117-124.
62. DFG. MAK- und BAT-Werte Liste, 2006. Mitteilung 38, Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Weinheim, Germany: Wiley-VCH ; 2006.
63. NIOSH. Criteria for a recommended standard. Occupational exposure to ethylene glycol monobutyl ether and ethylene glycol monobutyl ether acetate., 1990. Washington, DC, USA: US Dept. of Health and Human Services, Public Health Service, Centers for Disease Control ; 1990.
64. UK-HSE. Occupational exposure limits 2002. Norwich, UK; 2002.
65. Jakasa I Mohammadi N Kruse J Kezic S. Percutaneous absorption of neat and aqueous solutions of 2-butoxyethanol in volunteers. Int Arch Occup Environ Health 2004 ; 77: 79-84.
66. Corley RA Bormett GA Ghanayem BI. Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans. Toxicol Appl Pharmacol 1994 ; 129: 61-79.
67. Corley RA Markham DA Banks C Delorme P Masterman A Houle JM. Physiologically based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapor by humans. Fundam Appl Toxicol 1997 ; 39: 120-130.
68. Franks SJ Spendiff MK Cocker J Loizou GD. Physiologically based pharmacokinetic modelling of human exposure to 2-butoxyethanol. Toxicol Lett 2006 ; 162: 164-173.
69. Anundi H Langworth S Johanson G Lind ML Akesson B Friis L. Air and biological monitoring of solvent exposure during graffiti removal. Int Arch Occup Environ Health 2000 ; 73: 561-569.
70. Corley RA Gies RA Wu H Weitz KK. Development of a physiologically based pharmacokinetic model for propylene glycol monomethyl ether and its acetate in rats and humans. Toxicol Lett 2005 ; 156: 193-213.
71. Hubner B Lehnert G Schaller KH Welte D Angerer J. Chronic occupational exposure to organic solvents. XV. Glycol ether exposure during the manufacture of brakehoses. Int Arch Occup Environ Health 1992 ; 64: 261-264.
72. Jones K Dyne D Cocker J Wilson HK. A biological monitoring study of 1-methoxy-2-propanol: analytical method development and a human volunteer study. Sci Total Environ 1997 ; 199: 23-30.
73. Laitinen J. Biomonitoring of technical grade 1-alkoxy-2-propanol acetates by analysing urinary 2-alkoxypropionic acids. Sci Total Environ 1997 ; 199: 31-39.
74. Devanthery A Berode M Droz PO. Propylene glycol monomethyl ether occupational exposure. 3. Exposure of human volunteers. Int Arch Occup Environ Health 2002 ; 75: 203-208.
75. Devanthery A Dentan A Berode M Droz PO. Propylene glycol monomethyl ether (PGME) occupational exposure. 1. Biomonitoring by analysis of PGME in urine. Int Arch Occup Environ Health 2000 ; 73: 311-315.